SERIDERM Ag - Serigen Mediproducts Private Limited

Products

SERIDERM® Ag

Broad-Spectrum Protection, Reliable Healing

Seriderm® Ag is a complete wound healing solution powered by 98% silk protein and silver ions.

Seriderm® Ag offers accelerated wound healing and combats infections in a wide range of infected or high-risk wounds, including diabetic foot ulcers, bed sores, and second-degree burns.

Unmet Need

Seriderm® Ag addresses the unmet need for an advanced wound care product that is non-adherent, absorbent and promotes faster wound healing while tackling wound infections or a high risk of wound infections.

Applications of Seriderm® Ag

Our novel silver ion and silk protein-based wound dressing is suitable for the treatment of a wide range of infected or high-risk wounds, including –

USPs of Seriderm® Ag

Broad Spectrum Antimicrobial Protection

Seriderm® Ag exhibits broad-spectrum antimicrobial activity against a wide range of wound-related microorganisms, including multi-drug resistant organisms.

Sustained Silver Release

Seriderm® Ag is designed for the sustained release of silver ions over 7 days, extending antimicrobial protection and reducing the need for frequent dressing changes.

Faster Healing Powered By Silk

The novel silk-based composition of Seriderm® Ag modulates cellular pathways resulting in better vasculature and granulation tissue formation for expedited wound healing and reduction of inflammatory markers in wounds.

Moist Wound Healing Environment

Seriderm® Ag can absorb >900% of its weight and maintains optimal moisture at the wound environment for accelerated healing, with a moisture vapour transmission rate >1000 g/m²/24h.

Product Gallery

silver ion dressing seriderm ag

silver ion antimicrobial dressing

silver based wound care

advanced silver based wound dressing

Ravi Sarangpani

Consultant – Medical Devices

Accomplished medical device professional. Over 25 years in leadership roles in New Product Development, Quality & Regulatory Affairs, Marketing, Sales and Business Development.Proven track record of managing new product development from concept to market. Hands-on expertise in Risk Management, Design Verification & Validation, Excellent problem-solving ability. Strong background of interaction with KOLs, customers and trade channels in India and EMEA. Ravi Sarangpani has completed his Production Engineering in 1989 from K.J Somaiya College of Engineering, Mumbai University.

Consultant, Medical Devices

Self Employed – 2019 onwards
Consulting and Advisory Services for medical device and healthcare companies and start-ups. Mentor at Venture Center, Asia’s largest science-based incubator and Materials Science Center, Indian Institute of Science, Bengaluru. Faculty at AIM-Prime, training & guidance program for deep tech startups, initiative of Atal Innovation Mission and Niti Aayog implemented by Venture Center, Pune.

Adler Mediequip, A Smith & Nephew Company. Director NPD
2014 – 2019

Headed new product development for trauma, oncology and hip replacement for APAC region, 20-member team, USD 1m budget. Launched four new products in five years within budgets and targeted timelines. Implemented effective project management within a crossfunctional, multi-national, multi-locational project team. Developed and implemented design control procedure as per revised MDR that was adopted as model for implementation across sites.

Adler Mediequip. VP – Development & Quality Management
2010 – 2014

Headed Design, Quality and Regulatory Functions. Implemented structured D&D methodology, cross functional teams, ‘first time right’ culture for execution efficiency. Started in-house design verification including computational modeling and testing. Implemented GD&T across team and manufacturing organization. Launched 3 new products that contributed to successful clinical outcomes for 15000+ patients between 2012 – 2018. Designed innovative locking plate system for fractures that was granted patents in U.S, EU, Japan.

Sushrut Surgicals – A Sushrut-Adler Group Company
2001 – 2010 VP Marketing and Sales
1993 – 2000 Marketing Manager

Joined in start-up stage, grew business from $150k in 1993 to $3.6m by 2009. Established strong brand image and presence across India and 29 other countries. Developed KOL relationships that led to strong clinician driven product development.